Source: GWASCAT ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2736100
rs2736100
TERT
C 0.900 GeneticVariation GWASCAT Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility. 30714141

2019
dbSNP: rs498872
rs498872
PHLDB1
A 0.900 GeneticVariation GWASCAT Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility. 30714141

2019
dbSNP: rs6010620
rs6010620
RTEL1 ; RTEL1-TNFRSF6B
G 0.900 GeneticVariation GWASCAT Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility. 30714141

2019
dbSNP: rs2736100
rs2736100
TERT
C 0.900 GeneticVariation GWASCAT Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. 24908248

2014
dbSNP: rs6010620
rs6010620
RTEL1 ; RTEL1-TNFRSF6B
G 0.900 GeneticVariation GWASCAT Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. 24908248

2014
dbSNP: rs2736100
rs2736100
TERT
G 0.900 GeneticVariation GWASCAT Genome-wide association study of glioma and meta-analysis. 22886559

2012
dbSNP: rs4977756
rs4977756
CDKN2B-AS1
G 0.900 GeneticVariation GWASCAT Genome-wide association study of glioma and meta-analysis. 22886559

2012
dbSNP: rs6010620
rs6010620
RTEL1 ; RTEL1-TNFRSF6B
G 0.900 GeneticVariation GWASCAT Genome-wide association study of glioma and meta-analysis. 22886559

2012
dbSNP: rs2736100
rs2736100
TERT
0.900 GeneticVariation GWASCAT Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs2736100
rs2736100
TERT
0.900 GeneticVariation GWASCAT Combinations of newly confirmed Glioma-Associated loci link regions on chromosomes 1 and 9 to increased disease risk. 21827660

2011
dbSNP: rs4295627
rs4295627
CCDC26
0.900 GeneticVariation GWASCAT Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs498872
rs498872
PHLDB1
0.900 GeneticVariation GWASCAT Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs6010620
rs6010620
RTEL1 ; RTEL1-TNFRSF6B
0.900 GeneticVariation GWASCAT Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs2736100
rs2736100
TERT
G 0.900 GeneticVariation GWASCAT We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)). 19578367

2009
dbSNP: rs4295627
rs4295627
CCDC26
G 0.900 GeneticVariation GWASCAT We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)). 19578367

2009
dbSNP: rs4977756
rs4977756
CDKN2B-AS1
G 0.900 GeneticVariation GWASCAT We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)). 19578367

2009
dbSNP: rs498872
rs498872
PHLDB1
T 0.900 GeneticVariation GWASCAT We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)). 19578367

2009
dbSNP: rs6010620
rs6010620
RTEL1 ; RTEL1-TNFRSF6B
G 0.900 GeneticVariation GWASCAT We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)). 19578367

2009
dbSNP: rs6010620
rs6010620
RTEL1 ; RTEL1-TNFRSF6B
G 0.900 GeneticVariation GWASCAT Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. 19578366

2009
dbSNP: rs2252586
rs2252586 		T 0.860 GeneticVariation GWASCAT Using these data, we demonstrate two statistically independent associations between glioma and rs11979158 and rs2252586, at 7p11.2 which encompasses the EGFR gene (population-corrected statistics, P(c) = 7.72 × 10(-8) and 2.09 × 10(-8), respectively). 21531791

2011
dbSNP: rs11979158
rs11979158
EGFR
A 0.850 GeneticVariation GWASCAT Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21. 29743610

2018
dbSNP: rs11979158
rs11979158
EGFR
A 0.850 GeneticVariation GWASCAT Using these data, we demonstrate two statistically independent associations between glioma and rs11979158 and rs2252586, at 7p11.2 which encompasses the EGFR gene (population-corrected statistics, P(c) = 7.72 × 10(-8) and 2.09 × 10(-8), respectively). 21531791

2011
dbSNP: rs2853676
rs2853676
TERT
A 0.840 GeneticVariation GWASCAT Genome-wide association study identifies five susceptibility loci for glioma. 19578367

2009
dbSNP: rs2297440
rs2297440
RTEL1 ; RTEL1-TNFRSF6B
C 0.820 GeneticVariation GWASCAT Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21. 29743610

2018
dbSNP: rs2297440
rs2297440
RTEL1 ; RTEL1-TNFRSF6B
C 0.820 GeneticVariation GWASCAT Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. 28346443

2017